Anne Marie Clark of CAS discusses why companies are capitalizing on homegrown intellectual property, and takes a deeper look into the global tech transfer story.
In this article from The Patent Lawyer Magazine, Anne Marie Clark, Senior Search Analyst for CAS, discusses how to avoid patent pitfalls as the market for RNAi-derived therapeutics grows.
As part of the CPhI webinar series, CAS and IQVIA join forces to deliver insights into optimizing Artificial Intelligence and Machine Learning for predictive analytics, clinical trials and drug discovery in response to COVID-19.
To provide a better understanding and comparison of the diagnostic tests available in the fight against COVID-19, CAS has produced a report summarizing the basic principles of molecular and serological assays being used in diagnostic tests for SARS-CoV-2. The report highlights recent advancements in testing technologies and provides a high-level view of currently available diagnostic tests.